Compare iShares Global Clean Energy ETF (ICLN) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Clean Energy ETF vs Illumina, Inc. — how do they compare? iShares Global Clean Energy ETF trades at $18.54, while Illumina, Inc. trades at $192.36 (market cap $27.94B). The key difference: Illumina, Inc. is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| ICLN | ILMN | |
|---|---|---|
52-Week High | $23.75 | $194.33 |
52-Week Low | $13.41 | $91.00 |
Market Cap | — | $27.94B |
Sector | — | Health |
Enterprise Value | — | $29.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICLN trades at $18.52, up 0.82% today, while technical indicators show a bearish trend with moving averages signaling sell pressure. The ETF holds 105 global clean energy companies, benefiting from AI-driven electricity demand and high oil prices, yet faces policy risks. Recent news highlights its 29% YTD return outperforming the S&P 500, with a P/E of 25.7x and long-term EPS growth of 9.1% as of Seeking Alpha on June 7, 2026.
Outlook is mixed: bullish momentum from energy transition trends supports growth, but regulatory uncertainties and high valuation pose risks. Investors may see opportunity in the clean energy sector's structural shift, though volatility from policy changes requires caution.
Illumina (ILMN) trades at $192.53, up 3.15% today, with bullish technical signals and strong fundamental recovery. The stock shows robust profitability with a 19.42% net margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and new executive appointments, reinforcing growth prospects in genomics.
Outlook remains positive driven by sequencing demand and cost control, but risks include competitive pressure from Roche's new sequencer and China market weakness. Analyst consensus is Buy with a $178 target, though the current price exceeds this, suggesting cautious optimism amid execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
